By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharma Announces Recipients Of Innovation Grants Program 2016-2017 2/15/2017 8:05:26 AM
Ferring Pharma And Foresee Pharma Enter Into Exclusive Development And Option Agreement 2/13/2017 7:01:49 AM
Ferring Pharma And Enteris Biopharma Enter License Agreement To Develop An Oral Formulation Of A Peptide-Based Injectable Therapeutic 1/30/2017 6:42:43 AM
Ferring Pharma Partners With Intralytix To Develop Bacteriophage Treatments For Conditions Associated With The Microbiome And Drug-Resistant Bacteria 1/9/2017 10:51:00 AM
Ferring Pharma And IMAB Sign Licensing Agreement Granting IMAB Exclusive Rights In Asia To Olamkicept For The Treatment Of Autoimmune Disease 12/19/2016 10:22:19 AM
Ferring Pharma Receives EU Approval For REKOVELLE (Follitropin Delta) 12/13/2016 10:37:20 AM
BioGaia Associated Metabogen Starts Study On Intrahepatic Cholestasis Of Pregnancy With Ferring Pharma 12/7/2016 9:36:43 AM
Ferring Pharma Collaborates With Metabogen AB On Development Of Microbiome-Based Treatment For Intrahepatic Cholestasis Of Pregnancy (ICP) 12/5/2016 1:32:51 PM
Levo Therapeutics To License Exclusive Rights To Ferring Pharma' Orphan-Designated Drug, Carbetocin, For The Treatment Of Prader-Willi Syndrome 10/28/2016 7:29:59 AM
Ferring Pharma Receives Positive CHMP Opinion For REKOVELLE (Follitropin Delta) 10/17/2016 1:13:04 PM